Permanent and temporary staff with appropriate skills will be given opportunity to transfer
The Aenova Group, a European manufacturer of medicines and dietary supplements, is moving its tablet production facility from Berlin to two sites in the Bavarian region of Germany.
Faced with the ending of a leasing contract for the Wallenroder Strasse site in Berlin, which has been bought by a competitor, Aenova has decided to transfer all machinery, equipment and operations from the tablet production and packaging plant to Tittmoning and Bad Aibling.
As all the facilities at the Berlin plant are being transferred, Aenova says its overall capacity for manufacturing and packaging tablets will not be affected.
The firm says the 60 permanent employees in Berlin will be given the opportunity to move to one of the two Bavarian sites, and up to 50 temporary staff in Berlin with appropriate skills will be offered permanent positions.
Aenova says the move is a continuation of the strategic development of its production network, which has included leasing a new site in Lyon, France to serve the US market, as well as taking over a development facility near Basel, Switzerland, which has increased its capacity for the contract development of medicines.
The company says it will close its production plant for effervescent tablets in Ticino, Switzerland in June and move the operation to Bad Aibling.